BioTelemetry (BEAT) PT Raised to $74 at Raymond James
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Nasdaq eyes lower open after midterms-fueled surge as chip, data center stocks fall
- Massive market rotation raises question: Is the sell-AI trade here to stay?
- Goldman sees major AI and data center policy implications from ‘blue tsunami’
- Apple seeks to raise up to $7 billion in seven-tranche bond offering
- Nvidia chips stockpile in Hong Kong awaits China import approval - report
Tweet
Share
E-mailGet Alerts BEAT Hot Sheet
Price: $0.42 --0%
Rating Summary:
7 Buy, 8 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 20 | Down: 37 | New: 6
Rating Summary:
7 Buy, 8 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 20 | Down: 37 | New: 6
Join SI Premium – FREE
Raymond James analyst Jayson Bedford raised the price target on BioTelemetry (NASDAQ: BEAT) to $74.00 (from $64.00) while maintaining a Outperform rating.
Bedford said the Geneva deal offers a new source of growth/upside.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Materion Corp. (MTRN) PT Lowered to $232; KeyBanc: 'We would be aggressive buyers'
- Choice Hotels (CHH) PT Raised to $130 at Freedom Broker
- HubSpot Inc (HUBS) PT Lowered to $230 at Truist Securities as 'Headwinds Persis'
Create E-mail Alert Related Categories
Analyst Comments, Analyst PT ChangeRelated Entities
Raymond JamesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
